Dr Mark Ashton

BSc (Hons), PhD
Executive Director, IP Commercialisation

Mark joined UniQuest in 2010 and is currently the Executive Director of Intellectual Property Commercialisation. Prior to this he was the Manager of Innovation and Commercial Development for The Institute for Molecular Bioscience and Health Sciences at The University of Queensland.

Before joining UniQuest, Mark was the Executive Vice President, Business Development at the international biotech, Evotec AG, a company that focuses on drug discovery alliances and development partnerships with the pharmaceutical and biotech industry.  Prior to leading the business development group at Evotec, he was President, Discovery Services at Evotec, responsible for the company’s Drug Discovery division, a division that carried out projects involving high throughput screening, parallel synthesis and medicinal chemistry to pre-clinical development.

Mark has worked within the biotech and pharmaceutical industry since the early 1990s and has both operational and commercial experience of a wide range of life science projects. He has worked with most of the major pharmaceutical companies and a number of biotech companies around the world, negotiating agreements totalling more than $100 million.

Mark is the author and co-author of a number of peer reviewed scientific publications and patents including new chemical entities that have progressed to human clinical trials. He has a PhD in chemistry having worked on a medicinal chemistry-focused project sponsored by an international pharmaceutical company.

Contact:

+61 (07) 3365 4037
m.ashton@uniquest.com.au